Tue, 06th Apr 2021 17:26
Syncona Ltd - life sciences investor managed by Syncona Investment Management Ltd - Non-Executive Director Thomas Henderson sells 317,961 shares via Farla Ltd at GBP2.50, while Chris Hollowood, chief investment officer of SIML, sells 299,700 shares at GBP2.52, both on Thursday last week and together worth GBP1.6 million.
Current stock price: 248.00 pence
Year-to-date change: down 5.0%
By Tom Waite; thomaslwaite@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:
(Alliance News) - Syncona Ltd on Thursday said it has reached an agreement to sell one of its portfolio companies to US biotechnology firm, Century Th...
Syncona Ltd - London-based investor in healthcare companies - Notes that the loss of investee and clinical-stage biopharmaceutical company Achilles Th...
(Alliance News) - Syncona Ltd on Thursday noted the 2023 results of one of its life science portfolio companies, which showed a widened loss and an in...
Syncona Ltd - London-based investor in healthcare companies - Freeline Therapeutics Holdings PLC shareholders approve acquisition by Syncona.
Syncona (SYNC)